High yield expression, refolding, and characterization of recombinant interferon α2/α8 hybrids in Escherichia coli

Protein Expression and Purification

Volumn 31, Issue 2, 2003, Pages 222-230

  Platis, Dimitris ^a   Foster, Graham R ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI;

EID: 0142152531     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-5928(03)00187-6     Document Type: Article

References (36)

1. E. De Maeyer, J. Maeyer-Guignard, Type I interferons, Int. Rev. Immunol. 17 (1998) 53-73.
2. M.G. Katze, Y. He, M. Gale, Viruses and interferon: a fight for supremacy, Nat. Rev. Immunol. 2 (2002) 675-687.
3. S. Pestka, J.A. Langer, K.C. Zoon, C.E. Samuel, Interferons and their actions, Annu. Rev. Biochem. 56 (1987) 727-777.
4. G.R. Stark, I.M. Kerr, B.R. Williams, R.H. Silverman, R.D. Schreiber, How cells respond to interferons, Annu. Rev. Biochem. 67 (1998) 227-264.
5. B. Cohen, D. Novick, S. Barak, M. Rubinstein, Ligand-induced association of the type I interferon receptor components, Mol. Cell. Biol. 15 (1995) 4208-4214.
6. W. Klaus, B. Gsell, A.M. Labhardt, B. Wipf, H. Senn, The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution, J. Mol. Biol. 274 (1997) 661-675.
7. R. Radhakrishnan, L.J. Walter, A. Hruza, P. Reichert, P.P. Trotta, T.L. Nagabhushan, M.R. Walter, Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography, Structure 4 (1996) 1453-1463.
8. T. Senda, T. Shimazu, S. Matsuda, G. Kawano, H. Shimizu, K.T. Nakamura, Y. Mitsui, Three-dimensional crystal structure of recombinant murine interferon-beta, EMBO J. 11 (1992) 3193-3201.
9. M. Karpusas, M. Nolte, C.B. Benton, W. Meier, W.N. Lipscomb, S. Goelz, The crystal structure of human interferon beta at 2.2-A resolution, Proc. Natl. Acad. Sci. USA 94 (1997) 11813-11818.
10. M.O. Diaz, S. Bohlander, G. Allen, Nomenclature of human interferon genes, J. Interferon Res. 13 (1993) 243-244.
11. J. Hiscott, K. Cantell, C. Weissmann, Differential expression of human interferon genes, Nucleic Acids Res. 12 (1984) 3727-3746.
12. G.R. Adolf, Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1: evidence that IFN-omega 1 is a component of human leukocyte IFN, Virology 175 (1990) 410-417.
13. G.R. Foster, N.B. Finter, Are all type I human interferons equivalent?, J. Viral. Hepat. 5 (1998) 143-152.
14. L. Hibbert, G.R. Foster, Human type I interferons differ greatly in their effects on the proliferation of primary B cells, J. Interferon. Cytokine Res. 19 (1999) 309-318.
15. J. Kirkwood, Cancer immunotherapy: The interferon-alpha experience, Semin. Oncol. 29 (2002) 18-26.
16. S. Swaminathan, N. Khanna, Affinity purification of recombinant interferon-alpha on a mimetic ligand adsorbent, Protein Expr. Purif. 15 (1999) 236-242.
17. P.T. Liu, T.V. Ta, L.H. Villarete, High-yield expression and purification of human interferon alpha-1 in Pichia pastoris, Protein Expr. Purif. 22 (2001) 381-387.
18. K. Sugyiama, H. Ahorn, I. Maurer-Fogy, T. Voss, Expression of human interferon-alpha 2 in Sf9 cells. Characterization of O-linked glycosylation and protein heterogeneities, Eur. J. Biochem. 217 (1993) 921-927.
19. C. Rossmann, N. Sharp, G. Allen, D. Gewert, Expression and purification of recombinant, glycosylated human interferon alpha 2b in murine myeloma NSo cells, Protein Expr. Purif. 7 (1996) 335-342.
20. G.R. Foster, O. Rodrigues, F. Ghouze, E. Schulte-Frohlinde, D. Testa, M.J. Liao, G.R. Stark, L. Leadbeater, H.C. Thomas, Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency, J. Interferon. Cytokine Res. 16 (1996) 1027-1033.
21. L. Vuillard, C. Braun-Breton, T. Rabilloud, Non-detergent sulphobetaines: a new class of mild solubilization agents for protein purification, Biochem. J. 305 (1995) 337-343.
22. L. Vuillard, T. Rabilloud, M.E. Goldberg, Interactions of non-detergent sulfobetaines with early folding intermediates facilitate in vitro protein renaturation, Eur. J. Biochem. 256 (1998) 128-135.
23. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
24. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
25. A. Meister, G. Uze, K.E. Mogensen, I. Gresser, M.G. Tovey, M. Grutter, F. Meyer, Biological activities and receptor binding of two human recombinant interferons and their hybrids, J. Gen. Virol. 67 (Pt 8) (1986) 1633-1643.
26. G. Uze, M.T. Bandu, P. Eid, M. Grutter, K.E. Mogensen, Electrostatic interactions in the cellular dynamics of the interferon-receptor complex, Eur. J. Biochem. 171 (1988) 683-691.
27. C.H. Schein, Optimizing protein folding to the native state in bacteria, Curr. Opin. Biotechnol. 2 (1991) 746-750.
28. J. Schmitt, H. Hess, H.G. Stunnenberg, Affinity purification of histidine-tagged proteins, Mol. Biol. Rep. 18 (1993) 223-230.
29. J.F. Bazan, Haemopoietic receptors and helical cytokines, Immunol. Today 11 (1990) 350-354.
30. J.F. Bazan, Structural design and molecular evolution of a cytokine receptor superfamily, Proc. Natl. Acad. Sci. USA 87 (1990) 6934-6938.
31. K.R. Babu, S. Swaminathan, S. Marten, N. Khanna, U. Rinas, Production of interferon-alpha in high cell density cultures of recombinant Escherichia coli and its single step purification from refolded inclusion body proteins, Appl. Microbiol. Biotechnol. 53 (2000) 655-660.
32. M.A. Horisberger, S. Di Marco, Interferon-alpha hybrids, Pharmacol. Ther. 66 (1995) 507-534.
33. C.C. Chang, T.T. Chen, B.W. Cox, G.N. Dawes, W.P. Stemmer, J. Punnonen, P.A. Patten, Evolution of a cytokine using DNA family shuffling, Nat. Biotechnol. 17 (1999) 793-797.
34. J. Rhodes, J. Ivanyi, P. Cozens, Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids, Eur. J. Immunol. 16 (1986) 370-375.
35. J.R. Ortaldo, R.B. Herberman, C. Harvey, P. Osheroff, Y.C. Pan, B. Kelder, S. Pestka, A species of human alpha interferon that lacks the ability to boost human natural killer activity, Proc. Natl. Acad. Sci. USA 81 (1984) 4926-4929.
36. S. Yamamoto, H. Yano, O. Sanou, H. Ikegami, M. Kurimoto, M. Kojiro, Different antiviral activities of IFN-α subtypes in liver cell lines: synergism between IFN-α2 and IFN-α8, Hepatol. Res. 24 (2002) 99-106.